5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The breast cancer imaging market is segmented by Type of Imaging Technique, End User (Hospitals and Diagnostic Centers), and Geography
Fastest Growing Market:
Breast Imaging market is primarily driven by the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. According to Breast Cancer Care WA, it is estimated that in 2019, 19,371 Australian women were diagnosed with breast cancer or approximately 53 each day, which accounts for approximately 14% of all new cancer cases diagnosed in 2019. On the other hand, in breast imaging procedures the subject or patient is exposed to multiple sets of radiations for therapeutic purposes. However, radiation therapy is not always good for the patient’s health. Hence, the errors and side effects associated with breast screening is a major restraining factor for the growth of the market studied.
As per the scope, Breast imaging is a subspecialty of diagnostic radiology. It involves a range of imaging procedures with a wide variety of tools and technologies to screen, detect, and diagnose breast cancer. If cancer is detected, these tests help our doctors find the type of cancer, as well as determine the stage and location of cancer.
|By Type of Imaging Technique|
|Positron Emission Mammography|
|Image-guided breast biopsy|
|Other Imaging Techniques|
|By End Users|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The number of cancer patients in North America has witnessed a considerable rise. Prostate and breast cancer are the most prevalent forms of cancer in the region. According to BreastCancer.org, as of January 2019, there were more than 3.1 million women with a history of breast cancer in the United States and the death rates were higher for breast cancer than any other cancer.
The American Cancer Society is playing a vital role in early research to demonstrate the feasibility of mass screening for breast cancer, joining hands with the National Cancer Institute on the nationwide Breast Cancer Detection Demonstration Project. There are initiatives, such as the United States Preventive Services Task Force (USPSTF), made up of doctors and specialists who are researching ways to prevent diseases or detect them early. These societies are spreading awareness among people regarding the benefits of early breast cancer diagnosis and treatment. These factors, as well as the growing innovations in breast cancer imaging techniques, are expected to drive the global breast imaging market.
To understand geography trends, Download Sample Report.
Breast Imaging Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products and reducing the side effects of the procedures. Key players present in the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Breast Cancer
4.2.2 Technological Advancements in the Field of Breast Imaging
4.2.3 Investments and Initiatives from Various Organizations in Breast Cancer Screening Campaigns
4.3 Market Restraints
4.3.1 Risk of Adverse Effects from Radiation Exposure
4.3.2 High Cost of Imaging Systems
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Imaging Technique
5.1.2 Breast Ultrasound
5.1.3 Breast MRI
5.1.4 Positron Emission Mammography
5.1.5 Image-guided breast biopsy
5.1.6 Other Imaging Techniques
5.2 By End Users
5.2.2 Diagnostic Centers
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
5.3.3 Asia Pacific
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fujifilm Holdings Corporation
6.1.2 GE Healthcare
6.1.3 Hologic Inc.
6.1.4 General Medical Merate S.p.A.
6.1.5 Koninklijke Philips NV
6.1.6 Aurora Health Care
6.1.7 Canon Inc.
6.1.8 CMR Naviscan Corporation
6.1.9 SonoCine, Inc.
6.1.10 Siemens Healthineers
6.1.11 Dilon Technologies, Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments